Toronto General Hospital, University Health Network

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes	Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, autoimmune disease, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, immune system disorder, kidney disorder, metabolic disease, type 1 diabetes mellitus, urinary system disorder	Recruiting	Phase 2	2026-06-02		NCT05822609

Clinical trials